French D G
School of Nursing, Medical College of Ohio, Toledo, USA.
Nurse Pract. 1996 Sep;21(9):90, 96-7, 101-5; quiz 106-7. doi: 10.1097/00006205-199609000-00007.
Primary care providers are faced with numerous challenges when prescribing drugs for elderly patients. Multiple drug use, coexisting illness, and normal physiologic changes associated with aging place older persons at increased risk for adverse drug reactions (ADRs). Sample selection bias in drug clinical trials and inappropriate prescribing of contraindicated drugs contribute to the risk profile. Because multiple drug use and ADRs are relatively common in the elderly, special caution should be used when prescribing for this population. The primary care provider should have a good understanding of the factors that put the elderly at increased risk for ADR, the classes of drugs inappropriate for elderly patients, the physiologic changes of aging that may produce an altered pharmacologic response, and the issues associated with adherence to drug therapy. This article identifies factors that contribute to ADRs in the elderly and proposes strategies to reduce or avoid risk. Identifying and preventing ADRs in older Americans is a Healthy People 2000 health protection goal, perhaps more important given projected demographics over the next 20 to 30 years.
在为老年患者开药时,初级保健提供者面临着众多挑战。多种药物联用、并存疾病以及与衰老相关的正常生理变化,使老年人发生药物不良反应(ADR)的风险增加。药物临床试验中的样本选择偏差以及禁忌药物的不当处方也增加了风险。由于多种药物联用和ADR在老年人中相对常见,因此在为这一人群开处方时应格外谨慎。初级保健提供者应充分了解使老年人ADR风险增加的因素、不适用于老年患者的药物类别、可能导致药理反应改变的衰老生理变化以及与药物治疗依从性相关的问题。本文确定了导致老年人ADR的因素,并提出了降低或避免风险的策略。识别和预防美国老年人的ADR是“健康人民2000”的健康保护目标,考虑到未来20至30年的预计人口统计数据,这一目标或许更为重要。